Advisory Committee on Immunization Practices: Meeting, 33760 [E7-11789]

Download as PDF 33760 Federal Register / Vol. 72, No. 117 / Tuesday, June 19, 2007 / Notices healthcare providers working as a team approach. Activities will include implementation of family centered community interventions that will provide biweekly site visits to the person living with diabetes and provide follow-up and support for the participant and their family. Two family members, found with the highest risk factor rating, will also be intervened by the CHW/PdS. The CHW will reinforce educational messages on balance nutrition and physical activity and provide social support and coaching to the person living with diabetes and their family members. The CHW/PdSs will be trained in diabetes and community mobilization skills. A person living with diabetes and one high risk blood relative family members will receive an initial survey, to establish baseline to evaluate the model’s effectiveness. Participants will receive a nutrition questionnaire to assess their nutrition knowledge and practice to tailor the nutrition education information, and will also receive a questionnaire to assess the cost effectiveness of the CHW/PdS model. The Diabetes Intervention Group (DIG) and the 1st Degree Blood Relative Intervention Group (BRIG), will receive tri-weekly visits, lasting approximately 2 hours. During these sessions the initial survey, the nutrition questionnaire and the cost effectiveness questionnaire will be given by the CHW/PdS to the participants. The Diabetes Delayed Intervention Group (DDIG) and the 1st Degree Blood Relative Delayed Intervention Group (BRDIG), will receive an initial site visit, lasting approximately 2 hours. At this time the initial participant and family member survey will be administered by the CHW/PdS. After the intervention phase is completed, estimated time line being 18 months, the DDIG and the BRDIG will receive group educational sessions for a period of one hour for 16 weeks. There are no costs to respondents except their time to participate in the survey. ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Number of respondents Average burden per response (in hrs.) Total burden (in hours) Respondents Types of visits Diabetes Intervention Group (DIG) ....................... 1st Degree Blood Relative Intervention Group (BRIG). Diabetes—Delayed Intervention Group (DDIG) ... Every three weeks visit Every three weeks visit 363 363 17 17 2 2 12,342 12,342 First visit ....................... Weekly visits ................. First visit ....................... Weekly visit .................. Five (5) working days ... 363 11 1 16 1 16 1 2 1 2 1 1 726 5,808 726 5,808 55 ....................................... 1463 ........................ ........................ 37,807 1st Degree Blood Relative—Delayed Intervention Group (BRDIG). CHW/PdS, for 5 days during the intervention section, the CHW/PdS will complete a tool to determine the time and effort by the clinic personnel in serving the DIG, BRIG, DDIG, BRDIG members explain. Total ............................................................... Dated: June 13, 2007. Catina Conner, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–11779 Filed 6–18–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention rwilkins on PROD1PC63 with NOTICES Advisory Committee on Immunization Practices: Meeting Correction: This notice was published in the Federal Register on May 4, 2007, Volume 72, Number 86, page 25318. The matters to be discussed have been changed. Matters To Be Discussed: The agenda will include discussions on Vaccine Financing; Hepatitis A Post-Exposure VerDate Aug<31>2005 19:10 Jun 18, 2007 Jkt 211001 363 Prophylaxis which will include a VFC Vote; Cold Adapted Influenza Vaccine; Immunization Safety; Tdap-IPV-Hib Combination Vaccine (Pentacel); MCV4 Dose to 2 years; Vaccine Shortages; Economic Analyses of Vaccines; Evidence-Based Recommendations; Human Papillomavirus Vaccine; Update on HIV Vaccines; Childhood Immunization Schedule; Adult Immunization Schedule; Update on Pneumococcal Vaccines Working Group; Update on Vaccines during Pregnancy and Breastfeeding Working Group; Hepatitis B update on Adult Recommendations; and Agency updates. VFC Votes will be taken to add Pentacel to the Diphtheria, Tetanus, Pertussis Resolution; to the Haemophilus Influenza Type B Resolution and to the Polio Resolution pending the Food and Drug Administration approval for licensure of Pentacel. Amended to include a VFC Vote on FluMist. PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 Agenda items are subject to change as priorities dictate. Contact Person for More Information: Demetria Gardner, Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, 1600 Clifton Road, NE., (E–05), Atlanta, Georgia 30333, telephone 404/ 639–8836, fax 404/639–6258. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR. Dated: June 12, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–11789 Filed 6–18–07; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

[Federal Register Volume 72, Number 117 (Tuesday, June 19, 2007)]
[Notices]
[Page 33760]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-11789]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    Correction: This notice was published in the Federal Register on 
May 4, 2007, Volume 72, Number 86, page 25318. The matters to be 
discussed have been changed.
    Matters To Be Discussed: The agenda will include discussions on 
Vaccine Financing; Hepatitis A Post-Exposure Prophylaxis which will 
include a VFC Vote; Cold Adapted Influenza Vaccine; Immunization 
Safety; Tdap-IPV-Hib Combination Vaccine (Pentacel); MCV4 Dose to 2 
years; Vaccine Shortages; Economic Analyses of Vaccines; Evidence-Based 
Recommendations; Human Papillomavirus Vaccine; Update on HIV Vaccines; 
Childhood Immunization Schedule; Adult Immunization Schedule; Update on 
Pneumococcal Vaccines Working Group; Update on Vaccines during 
Pregnancy and Breastfeeding Working Group; Hepatitis B update on Adult 
Recommendations; and Agency updates. VFC Votes will be taken to add 
Pentacel to the Diphtheria, Tetanus, Pertussis Resolution; to the 
Haemophilus Influenza Type B Resolution and to the Polio Resolution 
pending the Food and Drug Administration approval for licensure of 
Pentacel. Amended to include a VFC Vote on FluMist.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Demetria Gardner, Immunization 
Services Division, National Center for Immunization and Respiratory 
Diseases, CDC, 1600 Clifton Road, NE., (E-05), Atlanta, Georgia 30333, 
telephone 404/639-8836, fax 404/639-6258.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both the CDC and ATSDR.

    Dated: June 12, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-11789 Filed 6-18-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.